PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Unveiling the role of tumor-infiltrating immune cells in endometrial carcinoma

Unveiling the role of tumor-infiltrating immune cells in endometrial carcinoma
2025-03-10
(Press-News.org)

 

A new review article published in Genes & Diseases sheds light on the complex molecular mechanisms through which tumor-infiltrating immune cells regulate endometrial carcinoma (EC). As one of the most prevalent gynecological cancers, EC continues to challenge researchers and clinicians due to its dynamic interaction with the immune microenvironment. This comprehensive review presents crucial insights into how immune cells influence tumor progression and how immune evasion strategies enable cancer cells to thrive.

The tumor microenvironment in EC consists of various immune cell populations, including T cells, B cells, macrophages, natural killer cells, and dendritic cells, each playing distinct roles in either controlling or promoting tumor growth. A major focus of the review is on immune checkpoint pathways, such as PD-1/PD-L1, which tumors exploit to suppress the immune response. These pathways create an immunosuppressive environment, preventing the body's natural defense mechanisms from eliminating cancer cells.

Additionally, the review discusses the role of cytokines, chemokines, and signaling pathways in shaping the immune landscape of EC. Key immune players like macrophages and regulatory T cells contribute to immune suppression, further complicating treatment efforts. The review highlights the clinical implications of understanding these molecular interactions, emphasizing how immunotherapies can be tailored to counteract immune evasion tactics and improve patient outcomes.

By dissecting the intricate immune-tumor interactions, the study underscores the importance of personalized medicine in treating EC. It calls for further research into biomarkers that can predict response to immunotherapies and strategies to overcome resistance to checkpoint inhibitors. The findings provide a strong foundation for future advancements in targeted cancer therapies.

This review offers a comprehensive understanding of how immune regulation impacts tumor progression. As research continues to evolve, these insights pave the way for innovative treatment strategies, ultimately improving outcomes for patients battling endometrial carcinoma.

 

# # # # #

Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.

Scopus CiteScore: 7.3

Impact Factor: 6.9

 

# # # # # #

 

More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/

Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/

All issues and articles in press are available online in ScienceDirect (https://www.sciencedirect.com/journal/genes-and-diseases ).

Submissions to Genes & Disease may be made using Editorial Manager (https://www.editorialmanager.com/gendis/default.aspx ).

Print ISSN: 2352-4820

eISSN: 2352-3042

CN: 50-1221/R

Contact Us: editor@genesndiseases.com

X (formerly Twitter): @GenesNDiseases (https://x.com/GenesNDiseases )

 

# # # # # #

Reference

Silu Ding, Yingying Hao, Yue Qi, Heng Wei, Jin Zhang, Hui Li, Molecular mechanism of tumor-infiltrating immune cells regulating endometrial carcinoma, Genes & Diseases, Volume 12, Issue 3, 2025, 101442, https://doi.org/10.1016/j.gendis.2024.101442

END


[Attachments] See images for this press release:
Unveiling the role of tumor-infiltrating immune cells in endometrial carcinoma Unveiling the role of tumor-infiltrating immune cells in endometrial carcinoma 2 Unveiling the role of tumor-infiltrating immune cells in endometrial carcinoma 3

ELSE PRESS RELEASES FROM THIS DATE:

Traditional Chinese medicine unlocks new potential in treating diseases through ferroptosis regulation

Traditional Chinese medicine unlocks new potential in treating diseases through ferroptosis regulation
2025-03-10
Innovative insights into the role of ferroptosis, a unique form of programmed cell death, are reshaping the landscape of disease treatment. This growing field highlights how Traditional Chinese Medicine (TCM) can effectively modulate ferroptosis, offering novel therapeutic approaches for various conditions, including cancer, cardiovascular diseases, neurodegenerative disorders, and organ injuries. The powerful bioactive compounds in TCM have demonstrated the ability to regulate iron metabolism, lipid peroxidation, and redox balance, positioning them as key players in advancing modern medicine.   With its rich history of holistic ...

MSU study pinpoints the impact of prenatal stress across 27 weeks of pregnancy

2025-03-10
MSU has a satellite uplink/LTN TV studio and Comrex line for radio interviews upon request. EAST LANSING, Mich. – A team of researchers at Michigan State University and the University of Michigan found new insights on the timing of prenatal stress and its effect on infant stress reactivity and temperament — including differences between genders. The study, published in Psychoneuroendocrinology, is the first to examine weekly stress across 27 weeks of pregnancy to pinpoint when it most affects a newborn’s stress response and temperament — two measures that indicate infant biobehavioral reactivity. “Prenatal ...

Biochemist’s impact on science and students honored

Biochemist’s impact on science and students honored
2025-03-10
Kayunta Johnson-Winters, an associate professor of chemistry and biochemistry at The University of Texas at Arlington, has been named a 2025 fellow of the American Society for Biochemistry and Molecular Biology. The honor recognition recognizes her contributions to biochemistry and molecular biology and her efforts to support junior faculty, women in science and student mentorship. “This is a tremendous honor and recognizes Kay’s important work in advancing our understanding of disease while mentoring junior faculty and student researchers,” said Morteza Khaledi, dean of UTA’s College of Science. “I’m pleased ...

ELF4: A key transcription factor shaping immunity and cancer progression

ELF4: A key transcription factor shaping immunity and cancer progression
2025-03-10
ELF4, a transcription factor belonging to the ETS family, has emerged as a pivotal regulator in cell differentiation, immune system function, and cancer progression. This newly published review underscores its molecular complexity and clinical significance, shedding light on its dual role in tumor suppression and oncogenesis.   ELF4 is highly expressed in various tissues, including hematopoietic cells, placenta, and the gastrointestinal tract. Its activity is tightly controlled through post-translational modifications and intricate signaling pathways, allowing it to modulate key physiological processes. Notably, ELF4 plays a critical ...

Updated chronic kidney disease management guidelines recommend SGLT2 inhibitors regardless of diabetes or kidney disease type

2025-03-10
Embargoed for release until 5:00 p.m. ET on Monday 10 March 2025    Follow @Annalsofim on X, Facebook, Instagram, threads, and Linkedin Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization they represent.          ----------------------------       1. ...

New research explores how AI can build trust in knowledge work

2025-03-10
In today’s economy, many workers have transitioned from manual labor toward knowledge work, a move driven primarily by technological advances, and workers in this domain face challenges around managing non-routine work, which is inherently uncertain. Automated interventions can help workers understand their work and boost performance and trust. In a new study, researchers explored how artificial intelligence (AI) can enhance performance and trust in knowledge work environments. They found that when AI systems provided feedback in real-time, performance and trust increased. The study, by researchers at Carnegie Mellon ...

Compound found in common herbs inspires potential anti-inflammatory drug for Alzheimer’s disease

Compound found in common herbs inspires potential anti-inflammatory drug for Alzheimer’s disease
2025-03-10
LA JOLLA, CA—The herb rosemary has long been linked with memory: “There’s rosemary, that’s for remembrance,” says Ophelia in Shakespeare’s Hamlet. So it is fitting that researchers would study a compound found in rosemary and sage—carnosic acid—for its impact on Alzheimer’s disease. In the disease, which is the leading cause of dementia and the sixth leading cause of death in the US, inflammation is one component that often leads to cognitive decline. Carnosic acid is an antioxidant and anti-inflammatory compound that works by activating enzymes that make up the body’s natural defense system. ...

Inhaled COVID vaccine begins recruitment for phase-2 human trials

2025-03-10
Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine. The AeroVax study, supported by $8M in funding from the Canadian Institutes of Health Research (CIHR), will test needle-free vaccines developed to provide protection from SARS-CoV-2. Led by Fiona Smaill and Zhou Xing, members of the Michael G. DeGroote Institute for Infectious Disease Research (IIDR) at McMaster, the multi-centre trial will evaluate the new vaccine in a broad study group, while also confirming ...

What’s in a label? It’s different for boys vs. girls, new study of parents finds

2025-03-10
A decades-old riddle poses the following scenario: A boy is injured in a car crash in which the father dies and is taken to the emergency room, where the doctor says, “I cannot operate on him—he’s my son.” Who, then, is the doctor? Many over the years have been stumped in not recognizing the answer: the mother.  Similarly, research has shown that adults instinctively think of men when asked to think of a person—they describe the most “typical” person they can imagine as male and assume storybook characters without a specified gender are men. A new study by psychology researchers shows that the way parents ...

Genes combined with immune response to Epstein-Barr virus increase MS risk

2025-03-10
In multiple sclerosis (MS), antibodies to the common Epstein-Barr virus can accidentally attack a protein in the brain and spinal cord. New research shows that the combination of certain viral antibodies and genetic risk factors can be linked to a greatly increased risk of MS. The study has been published in the journal PNAS and led by researchers at Karolinska Institutet, Sweden, and Stanford University School of Medicine, USA. An estimated 90 to 95 percent of adults are carriers of the Epstein-Barr virus (EBV) and have formed antibodies against it. Many become infected as children with few or no symptoms, but in young adults, the virus can cause glandular ...

LAST 30 PRESS RELEASES:

UC Study: Long sentences for juveniles make reentry into society more difficult

Death by feral cat: DNA shows cats to be culprits in killing of native animals

Plant Physiology is Searching for its Next Editor-in-Chief

Clothes dryers and the bottom line: Switching to air drying can save hundreds

New insights into tRNA-derived small RNAs offer hope for digestive tract disease diagnosis and treatment

Emotive marketing for sustainable consumption?

Prostate cancer is not a death knell, study shows

Unveiling the role of tumor-infiltrating immune cells in endometrial carcinoma

Traditional Chinese medicine unlocks new potential in treating diseases through ferroptosis regulation

MSU study pinpoints the impact of prenatal stress across 27 weeks of pregnancy

Biochemist’s impact on science and students honored

ELF4: A key transcription factor shaping immunity and cancer progression

Updated chronic kidney disease management guidelines recommend SGLT2 inhibitors regardless of diabetes or kidney disease type

New research explores how AI can build trust in knowledge work

Compound found in common herbs inspires potential anti-inflammatory drug for Alzheimer’s disease

Inhaled COVID vaccine begins recruitment for phase-2 human trials

What’s in a label? It’s different for boys vs. girls, new study of parents finds

Genes combined with immune response to Epstein-Barr virus increase MS risk

Proximity and prejudice: Gay discrimination in the gig economy

New paper suggests cold temperatures trigger shapeshifting proteins

Reproductive justice–driven pregnancy interventions can improve mental health

Intranasal herpes infection may produce neurobehavioral symptoms, UIC study finds

Developing treatment strategies for an understudied bladder disease

Investigating how decision-making and behavioral control develop

Rutgers researchers revive decades-old pregnancy cohort with modern scientific potential

Rising CO2 likely to speed decrease in ‘space sustainability’ 

Study: Climate change will reduce the number of satellites that can safely orbit in space

Mysterious phenomenon at center of galaxy could reveal new kind of dark matter

Unlocking the secrets of phase transitions in quantum hardware

Deep reinforcement learning optimizes distributed manufacturing scheduling

[Press-News.org] Unveiling the role of tumor-infiltrating immune cells in endometrial carcinoma